Delayed recovery after autologous peripheral hematopoietic cell transplantation: Potential effect of a high number of total nucleated cells in the graft

Transfusion

Volumn 50, Issue 12, 2010, Pages 2649-2659

  Trébéden Negre, Hélène ^a   Rosenzwajg, Michelle ^a   Tanguy, Marie Laure ^a   Lefrere, François ^a   Azar, Nabih ^a   Heshmati, Farhad ^a   Belhocine, Ramdane ^a   Vernant, Jean Paul ^a   Klatzmann, David ^a   Norol, Françoise ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKINE; ELASTASE; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEINASE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CELL COUNT; CELL HOMING; CONTAMINATION; CONVALESCENCE; CRYOPRESERVATION; ENGRAFTMENT; FEMALE; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTINUCLEAR CELL; QUANTITATIVE ANALYSIS;

ADULT; AGED; ANTIGENS, CD34; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; LEUKOCYTES; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 78649993960     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02746.x     Document Type: Article

References (31)

1. Sheridan WP, Begley CG, Juttner CA, Szer J, Bikto L, Maher D, McGrath K, Morstyn G, Fox R,. Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-4.
2. To LB, Dyson PG, Juttner CA,. Cell-dose effect in circulating stem-cell autografting. Lancet 1986; 2: 404-5.
3. Lowenthal RM, Sullivan SA, Parker N, Marsden KA,. G-CSF-primed bone marrow cells for autologous transplantation. Lancet 1996; 347: 1125.
4. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD,. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-31.
5. Bensinger W, Appelbaum F, Rowley S, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C,. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-55.
6. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W,. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-9.
7. Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, Masia CM, Centurioni R, Mancini S, Brunori M, Leoni P,. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 1998; 83: 329-37.
8. Schwartzberg L, Birch R, Blanco R, Wittlin F, Muscato J, Tauer K, Hazelton B, West W,. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993; 11: 369-74.
9. Dreger P, Kloss M, Petersen B, Haferlach T, Löffler H, Loeffler M, Schmitz N,. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970-8.
10. Papadopoulos KP, Ayello J, Tugulea S, Heitjan DF, Williams C, Reiss RF, Vahdat LT, Suciu-Foca N, Antman KH, Hesdorffer CS,. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support. J Hematother 1997; 6: 61-8.
11. Emminger W, Emminger-Schmidmeier W, Hocker P, Hinterberger W, Gadner H,. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 1989; 4: 415-20.
12. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R,. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-14.
13. Jansen EM, Hanks SG, Terry C, Akard LP, Thompson JM, Dugan MJ, Jansen J,. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both? Transfusion 2007; 47: 817-23.
14. Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H,. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Eur J Haematol 2007; 78: 21-8.
15. Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F,. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients. Bone Marrow Transplant 1999; 24: 971-9.
16. Lefrere F, Delarue R, Somme D, Levy V, Damaj G, Tu A, Porcher R, Audat F, Boulat C, Cavazzana-Calvo M, Buzyn A, Belanger C, Maillard N, Hermine O, Varet B,. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose. Transfusion 2002; 42: 443-50.
17. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D, De Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C,. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007; 47: 1268-75.
18. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R,. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007; 9: 348-55.
19. Fois E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D, Fermand JP, Arnulf B, Mounier N, Ertault M, Lotz JP, Galicier L, Raffoux E, Benbunan M, Marolleau JP, Larghero J,. Recovery, viability and clinical toxicity of thawed and washed hematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 2007; 40: 831-5.
20. Hoyt R, Szer J, Grigg A,. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285-7.
21. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC,. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-20.
22. Lapidot T, Dar A, Kollet O,. How do stem cells find their way home? Blood 2005; 106: 1901-10.
23. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T,. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845-8.
24. Valenzuela-Fernandez A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, Leduc D, Delaunay T, Lazarini F, Virelizier JL, Chignard M, Pidard D, Arenzana-Seisdedos F,. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 2002; 277: 15677-89.
25. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T,. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-94.
26. Levesque JP, Liu F, Simmons PJ, Betsuyaku T, Senior RM, Pham C, Link DC,. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 2004; 104: 65-72. (Pubitemid 38879839)
27. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Hershkoviz R, Alon R, Hardan I, Ben-Hur H, Naor D, Nagler A, Lapidot T,. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004; 103: 2981-9.
28. Lee S, Im SA, Yoo ES, Nam EM, Lee MA, Ahn JY, Huh JW, Kim DY, Lee SN, Kim MJ, Lee SJ, Chung WS, Seong CM,. Mobilization kinetics of CD34+ cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors. Stem Cells 2000; 18: 281-6.
29. Lioznov M, Dellbrugger C, Sputtek A, Fehse B, Kröger N, Zander AR,. Transportation and cryopreservation may impair hematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant 2008; 42: 121-8.
30. Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, Fowler DH, Bishop MR, Kang EM, Malech HL, Dunbar CE, Khuu HM, Wesley R, Yau YY, Bolan CD,. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008; 112: 2092-100.
31. Klumpp TR, Herman JH, Schnell MK, Goldberg SL, Mangan KF,. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT. Bone Marrow Transplant 1996; 18: 559-64.